glp 1 agonist contraindications Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus GLP-1 Receptor Agonists | New
Description
A., Winkley, K
Cardiovascular mortality was reported in 9 of the 11 studies
PMID 3033647
While preliminary studies and observational signals suggest potential thyroidal effects, no RCTs have evaluated progression of Hashimoto thyroiditis or Graves disease under GLP-1RA therapy [32,58]
Paulus WJ, Tschpe C
Current evidence suggests that Retatrutide may influence appetite signalling, metabolic regulation, and body-weight outcomes in clinical research settings
